Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in € Orebro, Sweden, 1963Sweden, -2010 1963-1975, 1976-1990 and 1991-2005.
| INTRODUCTION
An increasing incidence of ulcerative colitis (UC) has been reported in many geographical regions across the world. 1 However, recent data indicate that the incidence might be plateauing or even declining in some areas where an early incidence increase was observed in the mid-20th century. 2, 3 Despite this, UC is believed to be continuing to become more prevalent, as a result of the early onset of the disease and its chronic nature. 4 Assessment of temporal trends of UC is mostly based on the extrapolation of studies with short observation periods. 5, 6 Historically, an increasing incidence of UC was initially reported from North
America and northern parts of Europe, including several regions in Sweden. [5] [6] [7] [8] [9] [10] [11] [12] [13] Studies on the incidence of UC in the primary catchment area of € Orebro University Hospital, € Orebro, Sweden, have reported an increasing incidence rate from 2.7 per 100 000 inhabitants in 1939-1958 to 3.3 in 1963 to 14.9 per 100 000 inhabitants in 1987. 7, 9 However, the results are difficult to compare because of differences in case ascertainment and changes in diagnostic criteria.
In earlier decades, patients have often progressed in disease extent and been at high risk of colectomy. 14, 15 Langholz et al.
reported a 41% probability for progress in disease extent after 10 years among patients diagnosed with UC in Copenhagen, during 1962-1987. 14 The cumulative risk of colectomy 10 years after diagnosis has been estimated as 7.6%-28%. 15, 16 The extent to which the introduction of novel therapies has influenced the natural history of UC remains largely unknown. Some data indicate that the risk of colectomy has decreased because of the introduction of immunomodulators and more recently anti-tumour necrosis factor (TNF) agents, although the literature is inconsistent. [17] [18] [19] [20] Our study aimed to depict temporal trends of the incidence and prevalence of UC between 1963 and 2010. We also wanted to assess temporal trends in disease phenotype, in medication and in the risk of colectomy. To limit the influence of selection bias, we reextracted all information on patients that were diagnosed during the period 1963-1987, thereby applying the same diagnostic criteria and methods for case ascertainment for the entire study period.
| MATERIALS AND METHODS

| Study population
This is a general population-based study with a denominator of all residents in the € Orebro University Hospital primary catchment area, located in the central Sweden, comprising five municipalities (Askersund, Hallsberg, Kumla, Lekeberg and € Orebro). During the study period 1963 to 2010, the population increased by 26% from 150 177 to 189 603. 21 Of the registered residents in 2010, the mean age was 40.4 years, 49.4% were men and 12.9% were born abroad. 21 The corresponding mean age in the entire Swedish population was 41.1 years in 2010, and 49.8% were men and 14.7% were born abroad. 21 In the study region, all patients with suspected inflammatory bowel disease (IBD) are referred to the € Orebro University
Hospital. There are no private gastroenterologists in the area, and all colonoscopies and radiological and histopathological examinations are performed at the € Orebro University Hospital.
The study was approved by the Uppsala Regional Ethics Committee in 2010 (approval number: 2010/304).
| Case ascertainment
The medical records, including all endoscopy, laboratory, radiological and histopathological reports, of patients with suspected IBD have been recorded prospectively since 1976 in the archive of the Colitis Clinic, Department of Internal Medicine, € Orebro University Hospital.
The process of case ascertainment has been described in detail previously. 22 In short, patients with UC were identified by evaluation of all medical records in the archive, amended by computerised search in the county council's digital in-patient, out-patient and pri- When applicable, additional information was extracted from the medical records from the departments of surgery, paediatrics and infectious diseases.
| Diagnostic criteria and data collection
Patients were included if they fulfilled the Lennard-Jones criteria for UC, were diagnosed between 1 January 1963 and 31 December 2010 and lived within the catchment area at any time in the study period (during the course of their disease). 23 The date of the first endoscopy with findings consistent with UC was considered as date of diagnosis.
Where the diagnosis was changed from IBD unclassified or Crohn's disease to UC, the date of diagnosis was defined as the time of the first IBD diagnosis. When the exact date of diagnosis could not be established by retrospective evaluation, the date was approximated to the 15 of the month where possible, otherwise to the 1 of July of the year of diagnosis. Disease extent was classified according to the Montreal classification. 24 In all patients with a confirmed diagnosis of UC, Patients were censored at the time of death or migration.
| Statistical analysis
Age at diagnosis is presented as median and interquartile range (IQR).
Crude and age-standardised incidence rates were calculated aggregately over 5-year periods by the direct method. 27 The point prevalence was calculated for the 31 December 1965 and in every 5-year interval until 31 December 2010. The age and sex characteristics of the study population for each year of the study period were obtained from the governmental agency Statistics Sweden and were used for standardisation. 21 The € Orebro County population of 1999 was used as the comparison population. The incidence of UC was assumed to follow a Poisson distribution, and the incidence rate and the relevant 95% confidence intervals (CI) were calculated accordingly. The prevalence and the 95% CI were calculated assuming a binomial distribution. Time trends in the age-standardised incidence rate were evaluated for the 5-year aggregated rates using Poisson regression.
Poisson regression with adjustment for age was used to compare the incidence rate in men and women. Logistic regression with adjustment for age was used to evaluate differences in disease extent at diagnosis between men and women. Life tables and survival plots of time to colectomy, first progression in disease extent and the cumulative probability of receiving 5-aminosalicylic acids, systemic corticosteroids, immunomodulators and anti-TNF agents, were constructed using Kaplan-Meier analysis. Log-rank test was used to compare groups, both overall and pairwise. In the analysis of progression in disease extent, patients with extensive colitis at diagnosis were excluded.
Further, in the assessment of medical therapy, patients were censored in the event of colectomy, and only treatment before the event of colectomy was accounted for. Univariate and multivariate Cox proportional hazard regression models for potential risk factors for colectomy and progress in disease extent (sex, age and disease extent at diagnosis; Figure 1 ) were performed. Thus, in the multivariate models, variables were entered on the basis of their potential relevance to the outcome rather than for statistical reasons. Changes in the indication for colectomy between study periods were explored using chisquared test for trend. All tests were two-tailed, and a P < .05 was considered statistically significant. Bonferroni correction was used to adjust for multiple comparisons. Statistical analyses were performed using STATA version 13 SE (StataCorp. 2013, College Station, TX).
| RESULTS
We initially identified 2656 patients with a potential IBD diagnosis.
In total, 1228 fulfilled the Lennard-Jones criteria for UC. The
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The median age at diagnosis was 35 (24-51) years. Men were more often diagnosed with extensive colitis compared with women (ageadjusted odds ratio [OR] = 1.55; 95% CI 1.17-2.05; P = .005), while a lower proportion of men had proctitis at diagnosis (age-adjusted OR = 0.54; 95% CI 0.42-0.70; P < .001; Table 1 ).
| Incidence rate
The age-standardised mean annual incidence rate (IR) for every 5-year interval from 1963 to 2010 increased from 3.5 to 18.1 per 100 000 inhabitants during the study period (Table 2 ). This corresponds to an age-standardised incidence rate ratio (IRR) of 1.14 (95% CI 1.11-1.16; P < .01) for every 5-year interval of the study period with no signs of levelling-off ( Figure 2A ). The increasing incidence rate was evident in both men and women with IRRs of 1.11
(CI 1.08-1.15; P < .001) for every 5-year interval in men and of 1.17
(CI 1.13, 1.22; P < .001) in women. Men had a higher incidence rate across all age-groups (age-adjusted IRR for men vs women = 1.34; 95% CI 1.18-1.52; P < .01).
| Prevalence
Age-standardised point prevalence for every 5-year interval of the study is shown in Figure 2B . Table 4 ; Figure 3 ). The risk for colectomy did not differ by sex or age at diagnosis (Table 4) .
| Temporal trends in medical therapy
Temporal trends in the medical therapy of UC are depicted in Table 5 . Sulphasalazine become available in Sweden during the periods, there was no change in the probability of being treated with oral 5-aminosalicylates (Table 5 ).
Corticosteroids were available through the entire study period. A significant increase in use of oral corticosteroids occurred between the two earliest study periods (Table 5) . Early use, defined as use within 3 months from diagnosis, increased from 17% to 37%
(P = .02). The corresponding figures for any use of corticosteroids within 10 years from diagnosis were 37% and 70%, respectively (P < .01). No significant difference in use of corticosteroids was observed between the most recent study periods (Table 5) .
Thiopurines were initiated in selected cases in the mid-1980s.
An increasing probability of receiving thiopurines was observed during the two most recent periods. In total, 7% of patients diagnosed There are numerous reports on the incidence rates of UC, 1, 6 but the prevalence of the disease in well-defined geographical areas has rarely been described over long periods. 5, 28 The incidence and prevalence of IBD within the primary catchment area of € Orebro University Hospital have been described previously. 7, 9, 22, 29 In the first report by Carleson et al., an incidence of UC of 2.7 per 100 000 inhabitants in 1939-1958 was observed. 7 The study was based mainly on hospital in-patients, and it can be questioned whether the identification of patients was complete. Follow-up data revealed an increasing incidence from 3.3 per 100 000 inhabitants in 1963 to 14.9 per 100 000 inhabitants in 1987, when the Garland criteria were applied to define cases with UC. 30 Therefore, it is difficult to make direct comparisons between the two studies as diagnostic criteria as well as case ascertainment differed. To address this problem, we re-extracted data for information on diagnosis, disease characteristics and disease course in all cases using the Lennard- 9 and the corresponding figure in our study was 232 per 100 000 ( Figure 2B ) . However, the prevalence continued to increase during the entire study period. Previous studies have reported varying prevalence rates across Europe, from 2.4
per 100 000 inhabitants in Romania to 505 per 100 000 inhabitants in Norway, and the observed prevalence of 474 per 100 000 in our study is one of the highest in the world. 1 Similar to the increased prevalence over time, we observed a continuous increase in the incidence of UC. This finding is consistent T A B L E 2 Crude and age-standardised incidence rates of ulcerative colitis per 100 000 inhabitants aggregated over 5-year periods by the direct method Intriguingly in a report from Olmsted County, a similar pattern was seen in Minnesota, USA, for the early part of our study period , but in contrast to our findings the incidence rate in
Olmsted County then reached a plateau at a level of 8.8 per 100 000. 5 The persistent increase in incidence in our catchment area points to the influence of factors related to the exposome, as the temporal shift is too rapid to be accounted for by genetic changes.
Smoking is the most well-defined risk factor for IBD as numerous studies report that active smokers are at decreased risk of UC. 31, 32 Intriguingly, the proportion of never-smokers has increased continuously in Sweden since 1980. 33 However, the extent to which smoking habits and other environmental factors differ between the € Orebro region and the Olmsted County can only be speculated on.
In our cohort, the disease extent at diagnosis differed between sexes. Women were more often diagnosed with proctitis, while men more frequently had left-sided or extensive colitis at diagnosis. A similar pattern was observed in a recent regional study in Sweden. 12 One possible explanation might be differences in healthcare-seeking behaviour depending on sex, with a higher proportion of women seeking for mild morbidity and undiagnosed disease. 34 Consistent with previous data, 17,35,36 a substantial proportion (34.5%) of patients with proctitis at diagnosis progressed to left-sided colitis or extensive colitis during the follow-up of 10 years.
In our cohort, the cumulative rate of colectomy during the first 10 years after diagnosis was 13.5% (95% CI 11.1%-15.8%) for the total study period. This figure is similar to the rate of 15.6% (95% CI 12.5%-19.6%) observed in a meta-analysis of 14 population-based studies published between 1989 and 2013. 37 In contrast to previous cohort studies, exploring the rate of colectomy in one geographical area over a long period, 18, 20 we observed a decreasing cumulative risk for colectomy over time. The decrease is statistically significant when the first and last study periods are compared. Patients diagnosed in 1991-2005 had a 39% lower risk for all-cause colectomy compared to patients diagnosed during the first period (1963) (1964) (1965) (1966) (1967) (1968) (1969) (1970) (1971) (1972) (1973) (1974) (1975) ).
This result is consistent with a population-based study from Canada where a decrease in the risk for elective colectomy by 7.4% was observed between 1997 and 2009, while the rate of colectomy because of acute severe colitis refractory to medical therapy was stable. 19 Similarly, a 63% decrease in the 9-year risk for major surgery was observed between 1979 and 2011 in a register study from
Denmark by Rungoe et al. 38 The indications for colectomy in our material seem to be comparable with previous studies. 18, 39 The study period of the current study corresponds to major changes in the management of IBD, with increased usage of corticosteroids, 5-aminosalicylates and thiopurines between the two earliest study periods and a further increase in the use of thiopurines as well as the introduction of anti-TNF agents during the most recent study period (Table 5 ). Patients diagnosed during the last study period had a 34% and 9% probability of receiving thiopurines and anti-TNF agents within 10 years of diagnosis, respectively. These figures are in line with the 5-year probabilities of 22%-26% of receiving immunomodulators and 6%-11% of anti-TNF therapy, observed in other recent population-based cohorts. 17, 39, 40 Patients diagnosed in the first study period, when medical management options were restricted mainly to bowel rest, corticosteroids and sulphasalazine, appear to have a disproportionally higher risk for colectomy compared to the two later periods (Figure 3 ).
However, after adjustments for potential confounders, no significant decrease was found comparing period 1 (1963-1975) the study period, a shift from chronic active disease to acute severe colitis refractory to medical therapy, as the main indication for colectomy, seemed to occur (P = .04, Table S1 ). 44 The possibility cannot be excluded that the absence of statistical significance in patients diagnosed during the second period Period 1 9 6 3 -1 9 6 5 1 9 6 6 -1 9 7 0 1 9 7 1 -1 9 7 5 1 9 7 6 -1 9 8 0 1 9 9 1 -1 9 9 5 1 9 9 6 -2 0 applied to confirm or refute the diagnosis of UC. 23 Moreover, the combination of government-financed health care and the absence of private gastroenterologist in the area as well as the use of the Swedish identification number allowed us to follow patients over a long time period. 45 The study might be limited by the retrospective data collection.
To limit the impact of potential information bias, assessment of all case records at the Colitis Clinic, € Orebro University Hospital, was amended by identification through electronic systems. However, we
were not able to retrospectively assess disease severity over time and the possibility cannot be excluded that patients with an indolent disease course and few episodes of inflammation more often were overseen in the early part of the study period, since computerised systems were introduced in 1988. On the other hand, the retrospective acquisition of data allowed us to correct the diagnosis based on information recorded later in the follow-up period. The observed peak in incidence during 1975-1980 might reflect improved availability to health care and increased awareness of the disease, since the 'Colitis Clinic' was established in 1976. Overall, our results demonstrate an increasing incidence of UC, continuously during the entire study period, without any signs indicating that the incidence is about to level off.
Colonoscopy was introduced at € Orebro University Hospital in 1976, and since then, the extent of UC has been based on findings at colonoscopy in most cases. Several reports have shown that the extent of inflammation is underestimated by barium enema in a considerable proportion of patients. [46] [47] [48] Therefore, we might have underestimated the number of patients with extensive colitis in the early part of the study.
In conclusion, we observed an increasing incidence and prevalence of UC during the entire study period between 1963 and 2010.
Neither the incidence nor the prevalence seems to be levelling off.
The observed prevalence in 2010 is among the highest reported. In parallel, a decrease in the colectomy rate was observed, potentially reflecting improved medical treatments, specifically 5-aminosalicylates and thiopurines. Anti-TNF therapy within 10 years of diagnosis 4 (3-6) <.01 0 0 9 (6-12) <.01
All comparisons are performed by log-rank test, both overall and pairwise. Bonferroni correction was used to adjust for multiple comparisons. Pairwise comparison of period 1 (1963-1975) and period 2 (1976-1990 ).
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